[1]
|
Ng, S.C., Kaplan, G.G., Tang, W., et al. (2019) Population Density and Risk of Inflammatory Bowel Disease: A Pro-spective Population-Based Study in 13 Countries or Regions in Asia-Pacific. The American Journal of Gastroenterology, 114, 107-115. https://doi.org/10.1038/s41395-018-0233-2
|
[2]
|
Mak, W.Y., Zhao, M., Ng, S.C., et al. (2019) The Epidemiology of Inflammatory Bowel Disease: East Meets West. Journal of Gastroenterology and Hepatology, 35, 380-389. https://doi.org/10.1111/jgh.14872
|
[3]
|
汪海潮, 叶晨, 吴亚玲, 等. 肛周病变不同起病时间克罗恩病患者的临床特征和变化趋势[J]. 中华消化杂志, 2020(2): 99-100.
|
[4]
|
李浩, 王巧民, 李鸣涛, 等. 克罗恩病伴肛周病变的临床特征及相关因素分析[J]. 中国当代医药, 2019, 26(9): 57-60.
|
[5]
|
赵杰, 宋世铎, 朱新国. 克罗恩病、自噬和营养的关系研究进展[J]. 中华炎性肠病杂志, 2018(4): 311-312.
|
[6]
|
张义宝, 钟继红. 间充质干细胞在克罗恩病治疗中的应用研究进展[J]. 山东医药, 2021, 61(6): 90-94.
|
[7]
|
李菁, 钟丽坤, 梁列新. 克罗恩病诊断及疾病评估方法的研究进展[J]. 广西医学, 2017, 39(5): 693-695.
|
[8]
|
郭亚慧, 牛巍巍, 张晓岚. 炎症性肠病诊断与治疗的共识意见(2018年, 北京): 克罗恩病部分解读[J]. 临床荟萃, 2018, 33(12): 1077-1079.
|
[9]
|
Schwartz, D.A., Loftus, E.V., Tremaine, W.J., et al. (2002) The Natural History of Fistulizing Crohn’s Disease in Olmsted County, Minnesota. Gastroenterology, 122, 875-880. https://doi.org/10.1053/gast.2002.32362
|
[10]
|
Eglinton, T.W., Barclay, M.L., Gearry, R.B., et al. (2012) The Spectrum of Perianal Crohn’s Disease in a Population-Based Cohort. Diseases of the Colon & Rectum, 55, 773-777. https://doi.org/10.1097/DCR.0b013e31825228b0
|
[11]
|
Park, S.H., Aniwan, S., Scott, H.W., et al. (2019) Update on the Natural Course of Fistulizing Perianal Crohn’s Disease in a Population-Based Cohort. Inflammatory Bowel Diseases, 25, 1054-1060. https://doi.org/10.1093/ibd/izy329
|
[12]
|
Gupta, N., Bostrom, A.G., Kirschner, B.S., et al. (2010) Incidence of Stricturing and Penetrating Complications of Crohnʼs Disease Diagnosed in Pediatric Patients. Inflammatory Bowel Diseases, 16, 638-644.
https://doi.org/10.1002/ibd.21099
|
[13]
|
张昊悦, 王业皇, 吴燕兰. 克罗恩肛瘘发病机制的研究进展[J]. 广西医学, 2019, 41(24): 3193-3197.
|
[14]
|
Tozer, P.J., Lung, P., Lobo, A.J., et al. (2018) Review Article: Pathogenesis of Crohn’s Perianal Fistula-Understanding Factors Impacting on Success and Failure of Treatment Strategies. Alimentary Pharmacology & Therapeutics, 48, 260-269. https://doi.org/10.1111/apt.14814
|
[15]
|
Sandborn, W.J., Fazio, V.W., Feagan, B.G., et al. (2003) AGA Technical Review on Perianal Crohn’s Disease. Gastroenterology, 125, 1508-1530. https://doi.org/10.1016/j.gastro.2003.08.025
|
[16]
|
Cheng, F., Huang, Z. and Li, Z. (2020) Efficacy and Safety of Mesenchymal Stem Cells in Treatment of Complex Perianal Fistulas: A Meta-Analysis. Stem Cells International, 2020, Article ID: 8816737.
https://doi.org/10.1155/2020/8816737
|
[17]
|
Molendijk, I., Nuij, V.J.A.A., van der Meulen-de Jong, A.E., et al. (2014) Disappointing Durable Remission Rates in Complex Crohnʼs Disease Fistula. Inflammatory Bowel Diseases, 20, 2022-2028.
https://doi.org/10.1097/MIB.0000000000000148
|
[18]
|
Panés, J. and Rimola, J. (2017) Perianal Fistulizing Crohn’s Disease: Pathogenesis, Diagnosis and Therapy. Nature Reviews Gastroenterology & Hepatology, 14, 652-664. https://doi.org/10.1038/nrgastro.2017.104
|
[19]
|
Naji, A., Eitoku, M., Favier, B., et al. (2019) Biological Functions of Mesenchymal Stem Cells and Clinical Implications. Cellular and Molecular Life Sciences, 76, 3323-3348. https://doi.org/10.1007/s00018-019-03125-1
|
[20]
|
Uccelli, A., Moretta, L. and Pistoia, V. (2008) Mesenchymal Stem Cells in Health and Disease. Nature Reviews Immunology, 8, 726-736. https://doi.org/10.1038/nri2395
|
[21]
|
Ding, D.C., Shyu, W.C. and Lin, S.Z. (2011) Mesenchymal Stem Cells. Cell Transplantation, 20, 5-14.
https://doi.org/10.3727/096368910X
|
[22]
|
Young, H.E., Mancini, M.L., Wright, R.P., et al. (1995) Mesenchymal Stem Cells Reside within the Connective Tissues of Many Organs. Developmental Dynamics, 202, 137-144. https://doi.org/10.1002/aja.1002020205
|
[23]
|
Shi, Y., Wang, Y., Li, Q., et al. (2018) Immunoregulatory Mecha-nisms of Mesenchymal Stem and Stromal Cells in Inflammatory Diseases. Nature Reviews. Nephrology, 14, 493-507. https://doi.org/10.1038/s41581-018-0023-5
|
[24]
|
Lv, F.J., Tuan, R.S., Cheung, K.M., et al. (2014) Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells. Stem Cells, 32, 1408-1419. https://doi.org/10.1002/stem.1681
|
[25]
|
Molendijk, I., Bonsing, B.A., Roelofs, H., et al. (2015) Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cells Promote Healing of Refractory Perianal Fistulas in Patients with Crohn’s Disease. Gastroenterology, 149, 918-927.
https://doi.org/10.1053/j.gastro.2015.06.014
|
[26]
|
Zhang, J., Lv, S., Liu, X., et al. (2018) Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn’s Disease: A Randomized Controlled Clinical Trial. Gut and Liver, 12, 73-78. https://doi.org/10.5009/gnl17035
|
[27]
|
江滨, 时宏珍, 史央, 等. 自体脂肪干细胞移植治疗复杂性肛瘘的临床观察[J]. 中华结直肠疾病电子杂志, 2019, 8(6): 566-573.
|
[28]
|
García-Olmo, D., García-Arranz, M., Herreros, D., et al. (2005) A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation. Diseases of the Colon & Rectum, 48, 1416-1423.
https://doi.org/10.1007/s10350-005-0052-6
|
[29]
|
de la Portilla, F., Alba, F., García-Olmo, D., et al. (2013) Ex-panded Allogeneic Adipose-Derived Stem Cells (eASCs) for the Treatment of Complex Perianal Fistula in Crohn’s Disease: Results from a Multicenter Phase I/IIa Clinical Trial. International Journal of Colorectal Disease, 28, 313-323. https://doi.org/10.1007/s00384-012-1581-9
|
[30]
|
Barnhoorn, M.C., Wasser, M., Roelofs, H., et al. (2020) Long-Term Evaluation of Allogeneic Bone Marrow-Derived Mesenchymal Stromal Cell Therapy for Crohn’s Disease Perianal Fistulas. Journal of Crohn’s and Colitis, 14, 64-70.
https://doi.org/10.1093/ecco-jcc/jjz116
|
[31]
|
Schwandner, O. (2021) Stem Cell Injection for Complex anal Fistula in Crohn’s Disease: A Single-Center Experience. World Journal of Gastroenterology, 27, 3643-3653. https://doi.org/10.3748/wjg.v27.i24.3643
|
[32]
|
Panés, J., García-Olmo, D., Van Assche, G., et al. (2016) Expanded Allogeneic Adipose-Derived Mesenchymal Stem Cells (Cx601) for Complex Perianal Fistulas in Crohn’s Disease: A Phase 3 Randomised, Double-Blind Controlled Trial. The Lancet, 388, 1281-1290. https://doi.org/10.1016/S0140-6736(16)31203-X
|
[33]
|
张国兴, 石荣, 陈昌捷, 等. 间充质干细胞治疗克罗恩病肛瘘的研究进展[J]. 中国中西医结合外科杂志, 2019, 25(5): 846-850.
|
[34]
|
Mounayar, M., Kefaloyianni, E., Smith, B., et al. (2015) PI3kα and STAT1 Interplay Regulates Human Mesenchymal Stem Cell Immune Polarization. Stem Cells, 33, 1892-1901. https://doi.org/10.1002/stem.1986
|
[35]
|
Lightner, A.L. and Faubion, W.A. (2017) Mesenchymal Stem Cell Injections for the Treatment of Perianal Crohn’s Disease: What We Have Accomplished and What We Still Need to Do. Journal of Crohn’s and Colitis, 11, 1267-1276.
https://doi.org/10.1093/ecco-jcc/jjx046
|
[36]
|
Chen, X., Cai, C., Xu, D., et al. (2019) Human Mesenchymal Stem Cell-Treated Regulatory CD23(+)CD43(+) B Cells Alleviate Intestinal Inflammation. Theranostics, 9, 4633-4647. https://doi.org/10.7150/thno.32260
|
[37]
|
Fan, L., Hu, C., Chen, J., et al. (2016) Interaction between Mesenchymal Stem Cells and B-Cells. International Journal of Molecular Sciences, 17, 650. https://doi.org/10.3390/ijms17050650
|
[38]
|
Al-Ghadban, S. and Bunnell, B.A. (2020) Adipose Tissue-Derived Stem Cells: Immunomodulatory Effects and Therapeutic Potential. Physiology (Bethesda, Md.), 35, 125-133. https://doi.org/10.1152/physiol.00021.2019
|
[39]
|
秦菊, 江滨, 周春根. 脂肪间充质干细胞治疗复杂性肛瘘的机制探讨[J]. 医学研究杂志, 2022, 51(6): 181-183, 167.
|
[40]
|
Fontaine, M.J., Shih, H., Schäfer, R., et al. (2016) Unrav-eling the Mesenchymal Stromal Cells’ Paracrine Immunomodulatory Effects. Transfusion Medicine Reviews, 30, 37-43. https://doi.org/10.1016/j.tmrv.2015.11.004
|
[41]
|
Fu, X., Liu, G., Halim, A., et al. (2019) Mesenchymal Stem Cell Migration and Tissue Repair. Cells (Basel, Switzerland), 8, 784. https://doi.org/10.3390/cells8080784
|
[42]
|
Yang, F., Ni, B., Liu, Q., et al. (2022) Human Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Experimental Colitis by Normalizing the Gut Microbiota. Stem Cell Research & Therapy, 13, Article No. 475.
https://doi.org/10.1186/s13287-022-03118-1
|
[43]
|
Dhere, T., Copland, I., Garcia, M., et al. (2016) The Safety of Autologous and Metabolically Fit Bone Marrow Mesenchymal Stromal Cells in Medically Refractory Crohn’s Dis-ease—A Phase 1 Trial with Three Doses. Alimentary Pharmacology & Therapeutics, 44, 471-481. https://doi.org/10.1111/apt.13717
|
[44]
|
Duijvestein, M., Vos, A.C.W., Roelofs, H., et al. (2010) Autologous Bone Marrow-Derived Mesenchymal Stromal Cell Treatment for Refractory Luminal Crohn’s Disease: Results of a Phase I Study. Gut, 59, 1662-1669.
https://doi.org/10.1136/gut.2010.215152
|
[45]
|
Gregoire, C., Briquet, A., Pirenne, C., et al. (2018) Allogeneic Mesenchymal Stromal Cells for Refractory Luminal Crohn’s Disease: A Phase I-II Study. Digestive and Liver Disease, 50, 1251-1255.
https://doi.org/10.1016/j.dld.2018.08.015
|
[46]
|
Forbes, G.M., Sturm, M.J., Leong, R.W., et al. (2014) A Phase 2 Study of Allogeneic Mesenchymal Stromal Cells for Luminal Crohn’s Disease Refractory to Biologic Therapy. Clinical Gastroenterology and Hepatology, 12, 64-71.
https://doi.org/10.1016/j.cgh.2013.06.021
|
[47]
|
Dave, M., Menghini, P., Sugi, K., et al. (2017) Ultrasound-Guided Intracardiac Injection of Human Mesenchymal Stem Cells to Increase Homing to the Intestine for Use in Murine Models of Experimental Inflammatory Bowel Diseases. Journal of Visualized Experiments, No. 127, 55367. https://doi.org/10.3791/55367-v
|
[48]
|
Dietz, A.B., Dozois, E.J., Fletcher, J.G., et al. (2017) Autologous Mesenchymal Stem Cells, Applied in a Bioabsorbable Matrix, for Treatment of Perianal Fistulas in Patients with Crohn’s Disease. Gastroenterology (New York, N.Y. 1943), 153, 59-62. https://doi.org/10.1053/j.gastro.2017.04.001
|
[49]
|
Cho, Y.B., Park, K.J., Yoon, S.N., et al. (2015) Long-Term Results of Adipose-Derived Stem Cell Therapy for the Treatment of Crohn’s Fistula. Stem Cells Translational Medicine, 4, 532-537. https://doi.org/10.5966/sctm.2014-0199
|
[50]
|
Hu, J., Zhao, G., Zhang, L., et al. (2016) Safety and Therapeutic Effect of Mesenchymal Stem Cell Infusion on Moderate to Severe Ulcerative Colitis. Experimental and Therapeutic Medicine, 12, 2983-2989.
https://doi.org/10.3892/etm.2016.3724
|
[51]
|
Garcia-Olmo, D., Herreros, D., Pascual, I., et al. (2009) Expanded Adipose-Derived Stem Cells for the Treatment of Complex Perianal Fistula: A Phase II Clinical Trial. Diseases of the Colon & Rectum, 52, 79-86.
https://doi.org/10.1007/DCR.0b013e3181973487
|
[52]
|
de Groof, E.J., Sahami, S., Lucas, C., et al. (2016) Treat-ment of Perianal Fistula in Crohn’s Disease: A Systematic Review and Meta-Analysis Comparing Seton Drainage and Anti-Tumour Necrosis Factor Treatment. Colorectal Disease, 18, 667-675. https://doi.org/10.1111/codi.13311
|
[53]
|
Panes, J., García-Olmo, D., Van Assche, G., et al. (2017) Long-Term Ef-ficacy and Safety of Cx601, Allogeneic Expanded Adipose-Derived Mesenchymal Stem Cells, for Complex Perianal Fistulas in Crohn’s Disease: 52-Week Results of a Phase III Randomised Controlled Trial. Journal of Crohn’s and Co-litis, 11, S5.
https://doi.org/10.1093/ecco-jcc/jjx002.008
|
[54]
|
Panés, J., Bouma, G., Ferrante, M., et al. (2022) INSPECT: A Retrospective Study to Evaluate Long-Term Effectiveness and Safety of Darvadstrocel in Patients with Perianal Fistulizing Crohn’s Disease Treated in the ADMIRE-CD Trial. Inflammatory Bowel Diseases, 28, 1737-1745. https://doi.org/10.1093/ibd/izab361
|
[55]
|
Yang, Q., Chen, J., Zhu, Y., et al. (2019) Mesenchymal Stem Cells Ac-celerate the Remodeling of Bladder VX2 Tumor Interstitial Microenvironment by TGFβ1-Smad Pathway. Journal of Cancer, 10, 4532-4539.
https://doi.org/10.7150/jca.30788
|
[56]
|
Cabalzar-Wondberg, D., Turina, M., Biedermann, L., et al. (2021) Al-logeneic Expanded Adipose-Derived Mesenchymal Stem Cell Therapy for Perianal Fistulas in Crohn’s Disease: A Case Series. Colorectal Disease, 23, 1444-1450.
https://doi.org/10.1111/codi.15587
|
[57]
|
刘建伟, 刘建平, 吴玉怀. 间充质干细胞治疗克罗恩病相关性肛周瘘管的meta分析[J]. 临床荟萃, 2019, 34(4): 347-351.
|
[58]
|
Garcia-Olmo, D., Gilaberte, I., Binek, M., et al. (2022) Follow-Up Study to Evaluate the Long-Term Safety and Efficacy of Darvadstrocel (Mesenchymal Stem Cell Treatment) in Patients with Perianal Fistulizing Crohn’s Disease: ADMIRE-CD Phase 3 Randomized Controlled Trial. Diseases of the Colon & Rectum, 65, 713-720.
https://doi.org/10.1097/DCR.0000000000002325
|
[59]
|
Cheng, F., Huang, Z. and Li, Z. (2019) Mesenchymal Stem-Cell Therapy for Perianal Fistulas in Crohn’s Disease: A Systematic Review and Meta-Analysis. Techniques in Coloproctology, 23, 613-623.
https://doi.org/10.1007/s10151-019-02024-8
|
[60]
|
Ivanova-Todorova, E., Bochev, I., Mourdjeva, M., et al. (2009) Adipose Tissue-Derived Mesenchymal Stem Cells Are More Potent Suppressors of Dendritic Cells Differentiation Compared to Bone Marrow-Derived Mesenchymal Stem Cells. Immunology Letters, 126, 37-42. https://doi.org/10.1016/j.imlet.2009.07.010
|
[61]
|
Dong, L., Pu, Y., Zhang, L., et al. (2018) Human Umbilical Cord Mesenchymal Stem Cell-Derived Extracellular Vesicles Promote Lung Adenocarcinoma Growth by Transferring miR-410. Cell Death & Disease, 9, 218.
https://doi.org/10.1038/s41419-018-0323-5
|
[62]
|
Chen, J., Ma, L., Zhang, N., et al. (2018) Mesenchymal Stem Cells Promote Tumor Progression via Inducing Stroma Remodeling on Rabbit VX2 Bladder Tumor Model. International Journal of Biological Sciences, 14, 1012-1021.
https://doi.org/10.7150/ijbs.25200
|
[63]
|
Liu, C., Feng, X., Wang, B., et al. (2018) Bone Marrow Mesenchymal Stem Cells Promote Head and Neck Cancer Progression through Periostin-Mediated Phosphoinositide 3-Kinase/Akt/Mammalian Target of Rapamycin. Cancer Science, 109, 688-698. https://doi.org/10.1111/cas.13479
|
[64]
|
Belyakov, N., Knyazev, O., Fadeeva, N., et al. (2018) Combined Anticytokine and Local Mesenchymal Stem Cells Therapy Promotes Longer Healing of Simple Fistulas in Patients with Crohn’s Disease. Journal of Crohn’s and Colitis, 12, S71-S72. https://doi.org/10.1093/ecco-jcc/jjx180.096
|
[65]
|
Knyazev, O.V., Fadeeva, N.A., Kagramanova, A.V., et al. (2018) Stem Cell Therapy for Perianal Crohn’s Disease. Terapevticheskii Arkhiv, 90, 60-66. https://doi.org/10.26442/terarkh201890360-66
|